<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>OAR@UM Collection:</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/71407</link>
    <description />
    <pubDate>Sun, 19 Apr 2026 03:56:56 GMT</pubDate>
    <dc:date>2026-04-19T03:56:56Z</dc:date>
    <item>
      <title>Queen of Maltese hearts</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/71890</link>
      <description>Title: Queen of Maltese hearts
Abstract: Dr Ian Ellul catches up with the Superintendent of Public Health PROF. CHARMAINE GAUCI.</description>
      <pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/71890</guid>
      <dc:date>2020-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Clinical relevance of pharmacoepigenetics</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/71879</link>
      <description>Title: Clinical relevance of pharmacoepigenetics
Authors: Grech, Alfred; West, Stephen; Tonna, Ramon
Abstract: Epigenetics - defined as the inheritable changes that are not accompanied by alterations in DNA sequence - is a rapidly growing field and its research is being proposed for implementation into the clinical setting. Indeed, advances in epigenetics and epigenomics (which focuses on the analysis of epigenetic changes across the entire genome) can be applied in pharmacology. Specifically, its application has given rise to a new specialty called pharmacoepigenetics, which studies the epigenetic basis for the variation between individuals in their drug response. Pharmacoepigenetics can become one of the tools for the personalised medicine approach, with potentially safer treatments and less side-effects on the horizon.</description>
      <pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/71879</guid>
      <dc:date>2020-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Of Covid-19 and inflection points</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/71873</link>
      <description>Title: Of Covid-19 and inflection points
Abstract: SARS-CoV-2 is the latest addition to the family of coronaviruses - enveloped positive-sense RNA viruses - first identified in the 1960's. In a few weeks it has managed to shrink the GDP of the entire world. It exposed the economic fragility of some countries, yet showcased the resilience of others (including Malta). Key to this poise is the ability to mitigate the challenges posed by the pandemic on healthcare systems and social fabric.</description>
      <pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/71873</guid>
      <dc:date>2020-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>The Synapse : the Medical Professionals' Network : volume 19 : issue 3</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/71878</link>
      <description>Title: The Synapse : the Medical Professionals' Network : volume 19 : issue 3
Editors: Galea, Wilfred; Ellul, Ian C.
Abstract: Table of contents:; 1/ ELLUL, I. C. - Of Covid-19 and inflection points; 2/ CASSAR MAEMPEL, A. - Echocardiography; 3/ GRECH, A., WEST, S., &amp; TONNA, R. - Clinical relevance of pharmacoepigenetics; 4/ ELLUL I. C. - Queen of Maltese hearts; 5/ CHOUEIRY, P. - A brief review on the growing concept of nutraceuticals; 6/ SAMMUT, G. - The 'new psychoactive substances'; 7/ VASSALLO, P. - Venous thromboembolism</description>
      <pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/71878</guid>
      <dc:date>2020-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

